Search results for "COVID-19"
Latest on COVID-19 and bamlanivimab, vaccines, long-term effects
Bamlanivimab reduced viral load in mild to moderate cases when combined with etesevimab, new vaccine recommendations, research, and educational resources were released, and two studies provided longer-term data on patients who had COVID-19.
https://immattersacp.org/weekly/archives/2021/01/26/1.htm
26 Jan 2021
MKSAP Quiz: Evaluation for multiple myeloma
A 64-year-old man is evaluated following a recent diagnosis of multiple myeloma. Chemotherapy is planned to begin in 14 days. Which prophylactic therapy is indicated today?
https://immattersacp.org/weekly/archives/2023/12/05/3.htm
5 Dec 2023
COVID-19 research focuses on at-home testing, steroids, hydroxychloroquine, zinc
At-home testing worked, steroids' effects varied by C-reactive protein level, and hydroxychloroquine and zinc were ineffective for COVID-19, according to newly published studies.
https://immattersacp.org/weekly/archives/2020/07/28/1.htm
28 Jul 2020
Recent articles look at COVID-19 risk by blood type, ethical lessons, prone positioning
People in Italy and Spain with type A blood had increased risk of severe COVID-19, and prone positioning increased oxygenation, studies found. The FDA changed its position on hydroxychloroquine and ACP reaffirmed its stance.
https://immattersacp.org/weekly/archives/2020/06/23/1.htm
23 Jun 2020
Q&A with ACP's President on COVID-19 vaccines
George M. Abraham, MD, MPH, MACP, ACP's President, recently discussed the difference between third shots and boosters and other complexities of vaccination, as well as offered advice to internists on getting more patients vaccinated.
https://immattersacp.org/weekly/archives/2021/11/23/1.htm
23 Nov 2021
First COVID-19 vaccine receives interim recommendation, hydroxychloroquine ineffective for prophylaxis, and more
The FDA issued an emergency use authorization for the first mRNA vaccine against SARS-CoV-2, and the CDC's Advisory Committee on Immunization Practices made an interim recommendation for its use in those ages 16 years and older. Other research looked at postexposure prophylaxis, household SARS-CoV-2 transmission, and persistent COVID-19 symptoms.
https://immattersacp.org/weekly/archives/2020/12/15/1.htm
15 Dec 2020
COVID-19 studies look at transmission, cardiac effects, and lung ultrasound as triage
A review found most transmission to be respiratory, while a study suggested protection from eyeglasses. Data from athletes provided insight into cardiac effects, and lung ultrasound may be useful for triage. Philip A. Masters, MD, FACP, looked at how the pandemic has altered medicine.
https://immattersacp.org/weekly/archives/2020/09/22/1.htm
22 Sep 2020
New guidelines on COVID-19 antibody testing, flu vaccination and trial data on remdesivir
Infectious diseases experts offered guidance on the use of antibody tests in practice, a remdesivir trial showed disappointing results, the CDC recommended flu vaccination for people six months and up, and a study reported post-ICU outcomes of patients with COVID-19.
https://immattersacp.org/weekly/archives/2020/08/25/1.htm
25 Aug 2020
COVID-19 continues spread in U.S., CDC issues recommendations for high-risk patients
Those at higher risk from COVID-19 should take everyday precautions to keep space between themselves and others and avoid crowds as much as possible, the CDC said. Updated resources on COVID-19 for health care professionals are available from ACP and the CDC.
https://immattersacp.org/weekly/archives/2020/03/10/1.htm
10 Mar 2020
Latest research shows impact of COVID-19 on other health care
Hospitalizations for stroke and myocardial infarction, ED visits, cancer diagnoses, and trials for conditions other than COVID-19 all dropped during the pandemic, recent studies show.
https://immattersacp.org/weekly/archives/2020/08/11/1.htm
11 Aug 2020